ALDH2 and coronary artery disorder: Lastly, some targeted therapeutic approaches aimed at rescuing EC dysfunctions have emerged, i.e., lovastatin in the case of LMNA-DCM, fasudil for FD and empagliflozin in ALDH2 rs671-associated CAD.